Aftercare of Childhood Cancer Survivors in Switzerland
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorKantonsspital Aarau
About this trial
The Aftercare of Childhood Cancer Survivors in Switzerland (ACCS) study is a multicenter cohort study designed to investigate transition of follow-up care from pediatric oncology to adult care in a prospective and longitudinal way. The investigators collect data on preferences and expectations for follow-up care and transition to adult care by questionnaires in adolescent and young adult survivors of childhood cancer.
Eligibility criteria
Qualifiers
5-year survivor of childhood cancer
Diagnosis according to ICCC3 I-XII; Langerhans cell histiocytosis (LCH), Hemophagocytic lymphohistiocytosis (HLH)
Age at diagnosis <18 years
Age at study ≥16 years
Disqualifiers
Treatment only by means of surgery and without increased risk of late effects (e.g. teratoma)
<5 years after therapy of a relapse or palliative situation
Severe cognitive impairment, which makes it impossible to complete the questionnaire independently
Insufficient knowledge of the German language
Trial design
Treatments tested in this trial
- Transition model
Treatment groups
No treatment groups listed
Sponsors and collaborators
Kantonsspital Aarau
Lead sponsor
University Children's Hospital Basel
Collaborator
Luzerner Kantonsspital
Collaborator
Source ClinicalTrials.gov